(R)-Azasetron (besylate)
Product Sizes
25 mg
£ POA
HY-B0019C-25MG
5 mg
£ POA
HY-B0019C-5MG
10 mg
£ POA
HY-B0019C-10MG
100 mg
£ POA
HY-B0019C-100MG
50 mg
£ POA
HY-B0019C-50MG
10mM/1mL
£ POA
HY-B0019C-10MM
About this Product
- SKU:
- HY-B0019C
- Additional Names:
- SENS-401
- Application:
- Antibody Microarray
- CAS Number:
- 2025360-91-0
- Extra Details:
- (R)-Azasetron besylate (SENS-401) is an orally active calcineurin inhibitor. (R)-Azasetron besylate reduces Cisplatin (HY-17394)-induced hearing loss and cochlear damage[1][2].
- Molecular Weight:
- 507.99
- Purity:
- 98.78
- References:
- [1]Petremann M, et al. SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours. Otol Neurotol. 2019 Feb;40(2):254-263.|[2]Petremann M, et al. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats. Otol Neurotol. 2017 Oct;38(9):1355-1361.
- Research Area:
- Cancer
- Shipping Conditions:
- Ambient
- Storage Conditions:
- 4[o]C (Powder; sealed storage; away from moisture)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Metabolic Enzyme/Protease
